Literature DB >> 15493831

Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses.

Dietrich Mack1, Petra Becker, Indranil Chatterjee, Sabine Dobinsky, Johannes K M Knobloch, Georg Peters, Holger Rohde, Mathias Herrmann.   

Abstract

Biomaterial-associated infections, most frequently caused by Staphylococcus epidermidis and Staphylococcus aureus, are of increasing importance in modern medicine. Regularly, antimicrobial therapy fails without removal of the implanted device. The most important factor in the pathogenesis of biomaterial-associated staphylococcal infections is the formation of adherent, multilayered bacterial biofilms. In this review, recent insights regarding factors functional in biofilm formation of S. epidermidis, their role in pathogenesis, and regulation of their expression are presented. Similarly, in S. aureus the biofilm mode of growth affects gene expression and the overall metabolic status. Experimental approaches for analysis of differential expression of genes involved in these adaptive responses and evolving patterns of gene expression are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15493831     DOI: 10.1016/j.ijmm.2004.06.015

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  46 in total

1.  Disintegration of Staphylococcus epidermidis biofilms under glucose-limiting conditions depends on the activity of the alternative sigma factor sigmaB.

Authors:  Sebastian Jäger; Dietrich Mack; Holger Rohde; Matthias A Horstkotte; Johannes K-M Knobloch
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  mecA is not involved in the sigmaB-dependent switch of the expression phenotype of methicillin resistance in Staphylococcus epidermidis.

Authors:  Johannes K-M Knobloch; Sebastian Jäger; Jörn Huck; Matthias A Horstkotte; Dietrich Mack
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 3.  Antistaphylococcal vaccines and immunoglobulins: current status and future prospects.

Authors:  Stan Deresinski
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Analysis of different genetic traits and their association with biofilm formation in Staphylococcus epidermidis isolates from central venous catheter infections.

Authors:  D Petrelli; C Zampaloni; S D'Ercole; M Prenna; P Ballarini; S Ripa; L A Vitali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

5.  Clonality and occurrence of genes encoding antibiotic resistance and biofilm in methicillin-resistant Staphylococcus epidermidis strains isolated from catheters and bacteremia in neutropenic patients.

Authors:  Mohamed Salah Abbassi; Ons Bouchami; Arabella Touati; Wafa Achour; Assia Ben Hassen
Journal:  Curr Microbiol       Date:  2008-09-04       Impact factor: 2.188

6.  The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms.

Authors:  Riddhi Kharidia; Jun F Liang
Journal:  J Microbiol       Date:  2011-09-02       Impact factor: 3.422

Review 7.  Bacterial Extracellular Polysaccharides in Biofilm Formation and Function.

Authors:  Dominique H Limoli; Christopher J Jones; Daniel J Wozniak
Journal:  Microbiol Spectr       Date:  2015-06

Review 8.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

9.  Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation.

Authors:  Katherine J Lauderdale; Blaise R Boles; Ambrose L Cheung; Alexander R Horswill
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

10.  Staphylococcus aureus CcpA affects biofilm formation.

Authors:  Kati Seidl; Christiane Goerke; Christiane Wolz; Dietrich Mack; Brigitte Berger-Bächi; Markus Bischoff
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.